Medical Advocates

HCV Infection/Disease
  National Seroprevalence/Incidence Studies/
National Challenges

Global                            Russia/NISl
Africa   
Asia
Australia/Pacific Islands
Europe          
Latin America/Caribbean 
Middle East
North America









 

HCV Main Page Main New/Newsworthy  Home Page      

Last Update:  October 10, 2014
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Global
 

     Journal Papers, Abstracts, and Commentaries
 
 
Study identifies hepatitis C virus genotype 1 as the most prevalent worldwide.
[No authors listed]
Nurs Stand
. 2014 Aug 13;28(50):17.

Abstract

Historical epidemiology of hepatitis C virus (HCV) in selected countries.
Bruggmann P, Berg T, Ovrehus AL, et al
J Viral Hepat
. 2014 May;21 Suppl 1:5-33.
Abstract

Minimum costs for producing Hepatitis C Direct Acting Antivirals, for use in large-scale treatment access programs in developing countries.
Hill A, Khoo S, Fortunak J, et al
Clin Infect Dis
. 2014 Jan 6.
Abstract

FULL-TEXT ARTICLE
Hepatitis C virus in Arab world: a state of concern.

Daw MA, Dau AA.

ScientificWorldJournal
. 2012;2012:719494.
Paper

Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS.
Ford N, Singh K, Cooke GS,  et al

Clin Infect Dis
. 2012 Mar 19.
Abstract

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK, Mathers BM, Cowie B,  et al

Lancet
. 2011 Jul 27.
Abstract

Global estimates of prevalence of HCV infection among injecting drug users,
Aceijas C, Rhodes T.
 
Int J Drug Policy. 2
007 Oct;18(5):352-8.
Abstract
 

FULL TEXT ARTICLE
Epidemiology of hepatitis C virus infection.
Alter MJ.  
World J Gastroenterol. 2007 May 7;13(17):2436-41.
Paper

FULL-TEXT ARTICLE
Epidemiology of hepatitis C virus (HCV) infection.

Sy T, Jamal MM.

Int
J Med Sci. 2
006;3(2):41-6.
Paper
 

       Conference Reports, Abstracts, and Posters
 
  POSTER
Structural level interventions to increase needle/syringe access for preventing HIV and hepatitis C among people who inject drugs in low- and middle-income countries:
an international systematic review
D.C. Des Jarlais, J. Feelemyer, S. Modi, H. Hagan
(XIX International AIDS Conference)
Poster     Abstract

Africa
 

Cte d'Ivoire
 
     Journal Papers, Abstracts, and Commentaries
 
 
Intra-host diversity and evolution of hepatitis C virus endemic to Cte d'Ivoire.
Forbi JC, Campo DS, Purdy MA, et al
J Med Virol
. 2014 May;86(5):765-71.
Abstract
 

Egypt
 

     Journal Papers, Abstracts, and Commentaries
 
 
A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection.
Saad Y, Shaker O, Nassar Y,  et al
Gut Liver. 2014 Oct 7.
Abstract

A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013); Do they differ in Egypt?
El-Ghitany EM, Wahab MA, Wahab EW, et al
Liver Int. 2014 Jun 12
Abstract

FULL TEXT ARTICLE
The Association between Female Genital Cutting and Spousal HCV Infection in Egypt.
Kenyon CR, Colebunders R.
Int J Hepatol
. 2014;2014:164357.

Paper

Effectiveness and cost-effectiveness of immediate vs. delayed treatment of HCV-infected patients in a country with limited resources:
the case of Egyp
t.
Obach D, Deuffic-Burban S, Esmat G,  et al
Clin Infect Dis. 2014 Feb 7.
Abstract

FULL-TEXT ARTICLE
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.
Mohamoud YA, Mumtaz GR, Riome S, et al
BMC Infect Dis. 2013 Jun 24;13(1):288.
Paper

Updates of Lifetime Costs of Care and Quality of Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry into Care.
Farnham PG, Gopalappa C, Sansom SL, et al
J Acquir Immune Defic Syndr. 2013 Apr 22
Abstract

HCV burden of infection in Egypt: results from a nationwide survey.
Guerra J, Garenne M, Mohamed MK, Fontanet A. et al
J Viral Hepat. 2012 Aug;19(8):560-7
Abstract

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
Sievert W, Altraif I, Razavi HA, et al
Liver Int
. 2011 Jul;31 Suppl 2:61-80.
Abstract

Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A, Taylor SM, El-Daly M, et al

Liver Int
. 2010 Jan 29.

Abstract

Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.
Saleh DA, Shebl F, Abdel-Hamid M, et al  
Trans R Soc Trop Med Hyg.
2008 May 29.
Abstract
 

Senegal

     Conference Reports, Abstracts, and Posters
 
  Interest of dried blood spots (DBS) for genotyping hepatitis C virus among drug users in Senegal (ANRS 12243 UDSEN)
O. Ndiaye, J. Gozlan, H. Diop-Ndiaye et al
(XIX International AIDS Conference)
Abstract

Guinea-Bissau

     Journal Papers, Abstracts, and Commentaries
 

 
FULL TEXT ARTICLE
Hepatitis C virus infection in Guinea-Bissau: a sexually transmitted genotype 2 with parenteral amplification?
Plamondon M, Labbe AC, Frost E, et al 
PLoS ONE. 2007 Apr 18;2:e372.
Paper
 
FULL TEXT PDF ARTICLE
Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo,Madagascar.

Ramarakoto CE, Rakotomanana F, Ratsitorahina M, et al
BMC Infect Dis. 2008
Feb 29;8(1):25
Paper
 
Kenya
 
     Conference Reports, Abstracts, and Posters
 
  Social networks, risk factors and prevalence of HIV, HBV and HCV among drug users in Kenya
M.O. Oyaro, J. Wylie

(XIX International AIDS Conference)
Abstract

Madagascar
 

     Journal Papers, Abstracts, and Commentaries
 
  Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009.
Randriamanantany ZA, Rajaonatahina DH, Razafimanantsoa FE, et al
Transfus Clin Biol. 2012 Mar 10.
Abstract

Nigeria
 
     Journal Papers, Abstracts, and Commentaries
 
  Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.
Forbi JC, Purdy MA, Campo DS,  et al
J Gen Virol. 2012 Mar 28
Abstract

Urban-rural estimation of hepatitis C virus infection sero-prevalence in north Central Nigeria.
Forbi JC, Pietzsch J, Olaleye VO,  et a
l
East Afr J Public Health
. 2010 Dec;7(4):367-8.
Abstract
 

Ethiopia

      Journal Papers, Abstracts, and Commentaries
 
  Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia.
Alemayehu A, Tassachew Y, Sisay Z, Shimelis T.
BMC Res Notes. 2011 Jun 15;4(1):193.

Abstract

South Africa
 

     Journal Papers, Abstracts, and Commentaries
 
  Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa.
Gededzha MP, Selabe SG, Kyaw T, et al 

J Med Virol
. 2
012 Apr;84(4):601-7.
Abstract

 

Tanzania

      Journal Papers, Abstracts, and Commentaries
 
  Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital
in Dar Es Salaam, Tanzania.
Matee MI, Magesa PM, Lyamuya EF.
BMC Public Health. 2006 Jan 30;6:21.

Abstract
 
 
      Conference Reports, Abstracts, and Posters
 
  Risk factors associated with HCV infection and prevalence of HIV-HCV co-infection among people who inject drugs receiving medication-assisted treatment in
Dar es Salaam, Tanzania
O. Chang, R.D. Bruce, F. Masao, et al
(XX International AIDS Conference)
Abstract

Tunisia
 

      Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus infection among dialysis patients in Tunisia: Incidence and molecular evidence for nosocomial transmission.
Hmaied F, Ben Mamou M, Saune-Sandres K, et al   
J Med Virol.
2006 Feb;78(2):185-91.
Abstract

Uganda
 
      Journal Papers, Abstracts, and Commentaries
 
  Medicinal plants used in malaria treatment by Prometra herbalists in Uganda.
Adia MM, Anywar G, Byamukama R,  et al
J Ethnopharmacol
. 2014 Jun 11.

Abstract
 
      Conference Reports, Abstracts, and Posters
 
  Hepatitis C seroprevalence among HIV-positive and HIV-negative patients in Kampala, Uganda
J. O'reilly, P. Ocama, K. Opio, et al
(XVII International AIDS Conference)
Abstract


Asia
 

Regional/ Multinational
 
     Journal Papers, Abstracts, and Commentaries
 
  A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
Sievert W, Altraif I, Razavi HA, et al

Liver Int
. 2011 Jul;31 Suppl 2:61-80.
Abstract

China

     Journal Papers, Abstracts, and Commentaries
 

 
FULL-TEXT ARTICLE
Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China.
Cheng Z, Zhou B, Shi X,  et al
Chin Med J (E
ngl)
. 2014 Apr;127(7):1206-10.
Paper

Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population.
Tang S, Yue M, Wang J,  et al
Eur J Clin Microbiol Infect Dis
. 2014 Jan 7.
Abstract

The current HCV prevalence in China may have mainly resulted from an officially encouraged plasma campaign in the 1990s:
a coalescence inference with genetic sequences.
Lu L, Tong W, Gu L,  et al
J Virol
. 2013 Aug 28.

Abstract

Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.
Wang Z, Du J, Zhao M,  et al
Asia Pac Psychiatry
. 2012 Jul 27
Abstract

An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes,
12 subtypes, and two novel genotype 6 variants.

Gu L, Tong W, Yuan M, et al
J Clin Virol
. 2013 May 21
Abstract

Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to
genotype-2 infection and not relatedto interleukin-28B polymorphism.{
I-Shyan S, Chun-Yen L, Wen-Juei J, et al
Ann Hepatol
. 2013 Jan;12(1):62-9.
Abstract

Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV infected Veterans.
Akgn KM, Gordon K, Pisani M,  et al
J Acquir Immune Defic Syndr
.
2012 Oct 29
Abstract

FULL-TEXT PARTICLE
High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China.
Zhou YH, Yao ZH, Liu FL, et al
PLoS One
. 2012;7(8):e42937
Paper

FULL-TEXT PDF ARTICLE
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
Zhuang X, Liang Y, Chow EP, et al

BMC Infect Dis
. 2012 Jun 8;12(1):130.
Paper

Simultaneously high prevalence of hepatitis B and C virus infection in a population in Putian County, China.
Lu WP, Lin GX, Shi S, Dong JH.
J Clin Microbiol. 2012 Mar 7.

Abstract

FULL-TEXT ARTICLE
A possible geographic origin of endemic hepatitis C virus 6a in Hong Kong: evidences for the association
with Vietnamese immigration.

Zhou X, Chan PK, Tam JS, Tang JW.
PLoS One. 2011;6(9):e24889.
Paper

The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
Chan DP, Lee SS, Lee KC.

J Med Virol
. 2011 Jul;83(7):1187-94.
Abstract

The incidence of syphilis, HIV and HCV and associated factors in a cohort of men who have sex with men in Nanjing, China.
Hao C, Yan H, Yang H,  et al
Sex Transm Infect
. 2011 Jan 24
Abstract

Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures.
Zhou Y, Wang X, Hong G,  et al
J Clin Viro
l
. 2010 Sep 15.
Abstract

FULL-TEXT ARTICLE
High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China.
S
hang H, Zhong P, Liu J, et al
PLoS One. 2010 May 27;5(5):e10631.
Paper

FULL-TEXT ARTICLE
Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China.
Tan Y, Wei QH, Chen LJ,  
PLoS ONE
. 2008;3(10):e3608.
Paper

Viral hepatitis C in Hong Kong.
Leung N, Chu Bnurs C, Tam JS.
Intervirology. 2006 Jan-Apr;49(1-2):23-27
Abstract
 

      Conference Reports, Abstracts, and Posters
 
  HCV genotype and HBV co-infection associate with HCV clearance in HIV-positive subjects
Y. Dong, C. Qiu, X. Xia, et al
(XIX International AIDS Conference)
Abstract

India
 

     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Origin and Dynamics of HIV-1 Subtype C Infection in India.
Shen C, Craigo J, Ding M, Chen Y, Gupta P.

PLoS One
.
2011;6(10):e25956.
Paper

Japan
 

     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study.
Ishikane M, Watanabe K, Tsukada K,  et al
PLoS One
. 2014 Jun 19;9(6):e100517
Abstract

Analysis of the hepatic functional reserve, portal hypertension, and prognosis of patients with human immunodeficiency virus/hepatitis C virus coinfection through contaminated blood products in Japan.
Eguchi S, Takatsuki M, Soyama A,  et al
Transplant Proc. 2014 Apr;46(3):736-8.
Abstract

FULL-TEXT ARTICLE
Knowledge of HBV and HCV and Individuals' Attitudes Toward HBV- and HCV-Infected Colleagues: A National Cross-Sectional Study among a Working Population in Japan
Eguchi H, Wada K.
PLoS One
. 2013 Sep 26;8(9):e76921

Paper

FULL-TEXT ARTICLE
Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.
Himoto T, Masaki T.

Clin Dev Immunol
. 2012;2012:871401
Paper

Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders.
Kilbourne AM, McCarthy JF, Himelhoch S, et al
Gen Hosp Psychiatry
. 2008 Nov-Dec;30(6):495-500
Abstract
 

Myanmar

     Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype.
Lwin AA, Shinji T, Khin M, et al 
Hepatol Res. 2007 May;37(5):337-45

Abstract
 
      Conference Reports, Abstracts, and Posters
 
  Prevalence of Hepatitis B and C infections in more than 10000 HIV infected patients in Myanmar
Z. Sai Ko Ko, A. Thet Ko, Y. Moh Moh, et al
(XIX International AIDS Conference)
Abstract

Pakistan

     Journal Papers, Abstracts, and Commentaries

  Genetic History of Hepatitis C Virus in Pakistan.
Rehman IU, Vaughan G, Purdy MA,  et al
Infect Genet Evol. 2014 Aug 12.
Abstract

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan.
Ali A, Nisar M, Ahmad H, Saif N,
Virol J. 2011 Oct 9;8(1):466

Abstract
 

Singapore

     Journal Papers, Abstracts, and Commentaries
 

  FULL TEXT PDF ARTICLE
Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
Winslow M, Subramaniam M, Ng WL, et al

Singapore Med J.
2007 Jun;48(6):504-8.
Paper
 
Taiwan

     Journal Papers, Abstracts, and Commentaries
 
  Association between IPTA Gene Polymorphisms and Hematological Abnormalities in Hepatitis C Virus-Infected Patients Receiving Combination Therapy.
Hwang JJ, Lo CC, Lin CH,  et al
Gut Liver
. 2014 Oct 7.
Abstract

Hepatitis C virus infection among children in aboriginal areas in Taiwan.
Wu TC, Chuang WL, Dai CY, et al 
Trans R Soc Trop Med Hyg
. 2008 Jul 23.
Abstract

Thailand

     Journal Papers, Abstracts, and Commentaries
 
  Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand.
Bhanich Supapol W, Remis RS, Raboud J, et al
J Med Virol
. 2011 Jan;83(1):33-44.
3.
Abstract
Vietnam

     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Treatment of hepatitis C as prevention: a modeling case study in Vietnam.
Durier N, Nguyen C, White LJ.

PLoS One
.
2012;7(4):e34548.
Paper

Australia/Pacific Islands
 

Australia

  
Journal Papers, Abstracts, and Commentaries
 
 
Delivery of treatment for hepatitis C virus infection in the primary care setting.
Baker D, Alavi M, Erratt A, et al
Eur J Gastroenterol Hepatol. 2014 Jul 19
Abstract

Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions.
Brener L, Horwitz R, von Hippel C, et al
Psychol Health Med
. 2014 Jun 3:1-6
Abstract

A piece of the jigsaw of primary care: health professional perceptions of an integrated care model of hepatitis C management in the community.
Treloar C, Gray R, Brener L.
J Prim Health Care. 2014 Jun 1;6(2):129-34.
Abstract

Under the watchful eye of 'a benevolent dictator' - General practitioner and patient experiences of hepatitis C treatment initiation and
shared-care in general practice.
Hopwood M, Treloar C.
Aust Fam Physician. 2013 Dec;42(12):900-3.
Abstract

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.
Treloar C, Rance J, Dore GJ, Grebely J.
J Viral Hepat. 2013 Dec 3.
Abstract

Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.
Treloar C, Rance J, Backmund M.
Clin Infect Dis
. 2013 Aug;57 Suppl 2:S51-5.
Abstract

Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.
Cameron B, Galbraith S, Li H,  et al
J Viral Hepat. 2013 Apr;20(4):e96-e106.
Abstract

Safety and Effectiveness of a Nurse-Led Outreach Program for Assessment and Treatment of Chronic Hepatitis C in the Custodial Setting.
Lloyd AR, Clegg J, Lange J, , Monkley D. et al
Clin Infect Di
s
. 2013 Jan 29
Abstract

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.
Grebely J, Pham ST, Matthews GV, et al
Hepatology. 2011 Oct 26.
Abstract

Structural constraints on the training of peer educators in hepatitis C prevention.
Treloar C, Rance J, Laybutt B, Crawford S
Health Educ Res. 2011 Oct 10.
Abstract

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
Sievert W, Altraif I, Razavi HA, et al
Liver Int
. 2011 Jul;31 Suppl 2:61-80.
Abstract

Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia.
Gidding HF, Amin J, Dore GJ,  et al
J Hepatol
. 2010 Apr 10
Abstract

Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users.
Coupland H, Day C, Levy MT, Maher L
Health Promot J Austr. 2009 Dec;20(3):234-40.
Abstract

Hepatitis C virus infection rates and risk factors in an Australian hospital endoscopy cohort.
Vickery K, Tawk HM, Bisset L, 
Aust N Z J Public Health
. 2009 Oct;33(5):442
Abstract

Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
Wand H, Spiegelman D, Law M, et al  
Addiction
. 2009 Oct 5
Abstract

The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
Gidding HF, Topp L, Middleton M, et al
J Gastroenterol Hepatol.
2009 Oct;24(10):1648-54
Abstract

Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
Day CA, White B, Thein HH  
AIDS Care. 2008 Jan;2
0(1):116-23.
Abstract

Transmission of hepatitis C virus by needle-stick injury in community settings.
Haber PS, Young MM, Dorrington L  
J Gastroenterol Hepatol. 2007 Nov;22(11):1882-5
Abstract
 

The Philippines

     Journal Papers, Abstracts, and Commentaries
 
  FULL TEXT ARTICLE
The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants.
Yanase Y, Ohida T, Kaneita Y, et al
Bull World Health Organ. 2007 Feb;85(2):131-137
Paper


Middle East
 
     

Regional/Multinational
 
          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Epidemiology of hepatitis C in the middle east.
Fallahian F, Najafi A.
Saudi J Kidney Dis Transpl
. 2011 Jan-Feb;22(1):1-9.
Paper

Iran

          Journal Papers, Abstracts, and Commentaries
 

 
Genotyping Pattern among Iranian HCV Positive Patients.
Hajia M, Amirzargar A, Khedmat H,
I
ran J Public Health. 2010;39(2):39-44
Abstract

Seroprevalence of hepatitis C virus: the first population-based study from Iran.
Merat S, Rezvan H, Nouraie M, Jafari E,  
Int J Infect Dis
. 2010 Mar 31.
Abstract

FULL-TEXT ARTICLE
Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan.
Hajiani E, Masjedizadeh R, Hashemi J. et al
World J Gastroenterol. 2006 Nov 21;12(43):7025-7028.
Paper
 

Iraq
 
          Journal Papers, Abstracts, and Commentaries
 
  Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009.
Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA

Saudi Med J. 2011 Oct;32(10):1046-50.
Abstract

Israel

          Journal Papers, Abstracts, and Commentaries
  A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Cornberg M, Razavi HA, Alberti A, et al
Liver Int. 2011 Jul;31 Suppl 2:30-60.
Abstract

Pakistan

          Journal Papers, Abstracts, and Commentaries

 
Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis.
Aziz H, Raza A, Murtaza S, et al
Int J Infect Dis
. 2012 Nov 22.
Abstract

FULL TEXT PDF ARTICLE
Epidemiology of hepatitis C virus infection in Pakistan.
Raja NS, Janjua KA.
J Microbiol Immunol Infect. 2008 Feb;41(1):4-8.
Paper

FULL TEXT PDF ARTICLE
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users
in Pakistan.
Kuo I, Ul-Hasan S, Galai N, et al  

Harm Reduct J.
2006 Aug 16;3(1):26
Paper
 

Saudi Arabia
 
          Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia.
Madani TA.
Trans R Soc Trop Med Hyg
. 2008 Sep 11
Abstract
 
Turkey
 
        Journal Papers, Abstracts, and Commentaries
 
  Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey.
Altuglu I, Soyler I, Ozacar T, Erensoy S. 
Int J Infect Dis.
2007 Oct 15;
Abstract

Russia/New Independent States
 
     

Russia
 
        Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.
Heimer R, Eritsyan K, Barbour R, Levina OS.
BMC Infect Dis
.
2014 Sep 19;14(Suppl 6):S12.
Paper

 


HCV Main Page Main New/Newsworthy  Home Page      

National Seroprevalence/Incidence Studies
National Challenges